Dual apoC-II mimetic and apoC-III antagonist for hypertriglyceridaemia

Nature Reviews Cardiology, Published online: 13 February 2020; doi:10.1038/s41569-020-0351-6D6PV, a dual apolipoprotein C-II mimetic and apolipoprotein C-III antagonist, increases triglyceride lipolysis in mouse models of hypertriglyceridaemia.

Source: Nature Reviews Cardiology - February 12, 2020 Category: Cardiology Authors: Karina Huynh Source Type: research